Seymour LW, Fisher KD. British Journal of Cancer. 2016;114:357–61
Reviews
Recent Posts
- PsiOxus Therapeutics Announces Clinical Trial with Third Cancer Gene Therapy Treatment and Appointment of New Chief Medical Officer
- PsiOxus Therapeutics Announces First-in-Human Dosing of their Second Gene Therapy Cancer Treatment.
- PsiOxus Therapeutics to Collaborate with the Parker Institute for Cancer Immunotherapy
- PsiOxus Therapeutics Receives $15 Million Milestone Payment as Armed Oncolytic Virus Licensed to Bristol-Myers Squibb Achieves CTA
- PsiOxus Therapeutics is listed in FierceBiotech’s 2017 Fierce 15
